Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Depreciation and Depletion (2022 - 2023)

Bluejay Diagnostics' Depreciation and Depletion history spans 2 years, with the latest figure at $22342.0 for Q4 2023.

  • For Q4 2023, Depreciation and Depletion fell 27.18% year-over-year to $22342.0; the TTM value through Dec 2023 reached $648708.0, up 314.25%, while the annual FY2024 figure was $75618.0, 88.34% down from the prior year.
  • Depreciation and Depletion for Q4 2023 was $22342.0 at Bluejay Diagnostics, down from $253174.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $253175.0 in Q2 2023 and bottomed at $22342.0 in Q4 2023.